Analysis of Artificial Insemination market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global artificial insemination market is projected to rise rapidly at a CAGR of 7% from 2022 to 2026. At present, the market is valued at US$ 1.9 billion and is anticipated to reach US$ 2.5 billion by 2026-end.
Artificial Insemination processes are widely performed in fertility centers. Continuous support by government organizations to fertility centers may also give newcomers more business opportunities. Several fertility centers are collaborating with other clinics to offer more services.
Artificial Insemination Market Size (2022)
US$ 1.9 Billion
Projected Market Value (2026)
US$ 2.5 Billion
Global Market Growth Rate (2022-2026)
Market Share of Intrauterine Insemination
Key Companies Profiled
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
“Rise in Infertility Rates Driving Demand for Artificial Insemination Techniques”
According to Fact.MR, a market research and competitive intelligence provider, the artificial insemination market is projected to increase at a CAGR of 7% from 2022 to 2026.
A medical procedure known as artificial insemination involves placing sperm in a female's womb on intent through methods other than sexual contact to induce pregnancy. Human fertility treatments such as artificial insemination are also frequently used in animal breeding.
Those who receive artificial insemination include infertile couples and single mothers. The most extensively used artificial insemination technique is intrauterine insemination. The expansion of the market is also being supported by bettering veterinary artificial insemination services and increased spending on animal healthcare.
One of the key factors affecting the market is the rising infertility rates, which are being accompanied by a rise in public knowledge of alternative reproductive treatments.
Additionally, governments in many countries have made same-sex marriage legal and are offering insurance coverage to civil unions for artificial insemination operations, both of which are fostering market expansion.
In addition, the necessity for artificial insemination among domestic livestock animals is being fueled by the expanding world population and the rising need for animal-based protein.
Artificial insemination is a painless treatment that can be done with or without anesthetics. Many hospitals that specialize in treating infertility have increased significantly during the last few years.
“Growing Public Awareness about New Technologies for Reproductive Treatments”
The market for artificial insemination is driven by the rising incidence of infertility in both men and women. Because more individuals are developing illnesses such as erectile dysfunction and polycystic ovary syndrome (PCOS), infertility is becoming increasingly prevalent globally.
Problems may arise from alterations in lifestyle and the desire of more working women to have children later in life. Men may find it challenging to become pregnant for a variety of reasons, including stress, alcohol consumption, lifestyle changes, and a decline in sperm quantity and motility.
Artificial insemination is frequently used as the first treatment for infertility, even though in vitro fertilization is thought of as a more sophisticated type of assisted reproductive technology.
Multinational pharmaceutical companies' rapid development of medicines that are undergoing clinical and preclinical research, as well as their release of new insemination kits with established potential advantages, are driving the growth of the artificial insemination market.
A significant opportunity has been generated for this industry by the invention of novel intracytoplasmic sperm injection (ICSI) for kid production, which is implanted in the ovum of females.
Due to factors such as the rising global rate of infertility, changing lifestyles, and modern women's growing preference for Planned Parenthood because of their uninterrupted full-time professions, the artificial insemination market is predicted to rise over the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Lack of Qualified Professionals & High Cost of Artificial Insemination Procedures”
The market growth will be restrained by factors such as a lack of specialized veterinary artificial insemination techniques, a large risk of diseases, and the possibility of birth defects in children for human reproduction.
The artificial insemination market will face difficulties due to a shortage of qualified professionals. The artificial insemination market is being constrained by the strict laws that most countries have enacted about who is eligible to get fertility treatments.
The cost is a major deterrent to artificial insemination among people. A few IUI and IVF cycles are provided for free by some governments, although the success rate is just average. Additionally, in some locations, couples who share the same gender are not covered by health insurance for assisted reproductive technology (ART).
“New Market Players Focusing on Developing Safe & Effective Artificial Fertility Procedures”
Emerging market players have concentrated on developing safe and effective artificial fertility procedures. To establish themselves in the market, new entrants are concentrating on brand-new product releases and strategic partnerships with leading market competitors.
“Increasing Adoption of Advanced Artificial Insemination Processes in North America”
North America is one of the world's top providers of healthcare facilities, and as a result, it leads the industry in terms of resources available and widespread public knowledge.
Due to its developed healthcare system and rising adoption of advanced artificial insemination processes, North America holds dominance in the artificial insemination market. The presence of significant key players and kind rules and regulations is expected to boost the market growth in the region over the forecast period.
“Increase in Government Support for Fertility Insurance in the U.S.”
Government support for fertility insurance and greater awareness of the treatment option for infertility are the factors supporting the market growth in the U.S.
Assisted reproductive technology, which includes methods for treating infertility such as artificial insemination and hormone therapy is the factor driving the market revenue in the country.
“High Demand for Fertility Treatments in Animal Production Industry”
The China artificial insemination market is anticipated to rise at a CAGR of 6.5% from 2022 to 2026.
Market growth is attributed to increased patient awareness of available treatments. In China, the social stigma attached to ARTs is gradually fading. Due to fewer strict laws and rising rates of infertility among the population, the market is expected to experience significant growth.
Increasing demand for artificial insemination in the animal production industry is driving market expansion in China.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“Intrauterine Insemination Widely Used to Treat Infertility Due to its Highest Pregnancy Rate”
Based on type, the artificial insemination market is divided into intrauterine insemination, intravaginal insemination, intratubal insemination, and others. Intrauterine insemination accounts for 70% share of the global market.
A type of fertility therapy called intrauterine insemination seeks to increase the amount of sperm inside the woman's uterus to speed up fertilization. Comparing the cost of intrauterine insemination to other reproductive treatment choices, it is a less invasive and less expensive method.
The probability of becoming pregnant has increased as a result of intrauterine insemination (IUI) technology. Age, infertility cause, a medication used, and other factors affect how well an IUI process works. The IUI treatment is safe, but it can occasionally result in multiple pregnancies, which can have major health effects on both the mother and the unborn child.
Newborns could be underweight and premature. Other therapies using assisted reproductive technology (ART) are more expensive than the IUI process. The IUI method yields greater results than any other fertility medication. Natural fertilization is possible due to this fertility technique.
Because the rate of infertility is rising, researchers are concentrating on issues affecting both men’s and women's health. Several medications are used to treat infertility issues or increase female fertility.
Demand for intrauterine insemination (IUI) therapy is being driven by several factors, including the increasing average age of first pregnancies, rising out-of-pocket healthcare costs, and technological advancements in devices with improved sensitivity.
Gynecological problems that make it difficult to conceive have become more common as a result of changing lifestyles. Demand for intrauterine insemination treatments is anticipated to rise as a consequence of the growing use of fertility treatment alternatives to increase the chances of conception.
“Wide Availability of Medical Facilities for Infertility Treatments in Fertility Centers”
Based on facility type, the market is segmented into hospitals, fertility centers, and home-based. The largest share of the global artificial insemination market is held by fertility centers. Several medical facilities providing artificial fertility treatments have increased recently as a result of rising fertility rates around the world.
All forms of artificial insemination can be performed at fertility centers. Most intrauterine insemination and intratubal insemination operations are performed in fertility centers.
A consultation is necessary to determine the woman's expected ovulation date before beginning the insemination procedure at a clinic. Additionally, your doctor may prescribe medication to improve your chances of conceiving.
Top artificial insemination companies' main strategy is to expand both, their geographic reach and their product offerings. This helps market participants increase their market penetration and product portfolio diversification.
For instance :
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
Currently, the artificial insemination market stands at US$ 1.9 billion.
The artificial insemination market is set to expand at 7% CAGR through 2026.
Rocket Medical PLC, Vitrolife AB, and Genea Limited are top artificial insemination service providers.
The market for artificial insemination is set to reach US$ 2.5 billion by 2026.
The U.S., Japan, Canada, Germany, and China are the top 5 countries in this space.
The market in Germany is set to rise at 5.4% CAGR through 2026.
Intrauterine insemination accounts for 70% share of the global market.
Need An Exclusive Report For Your Unique Requirement?